Gamma-delta T-cell receptor (γδ T-cell receptor) (γδ TCR)

The **γδ T-cell receptor (γδ TCR)** is a heterodimeric cell-surface receptor expressed predominantly on γδ T cells, a distinct subset of T lymphocytes. Unlike classical αβ T-cell receptors, the γδ TCR recognizes a range of antigens without presentation by traditional major histocompatibility complex (MHC), including small phosphorylated molecules known as phosphoantigens (PAgs), as well as stress-induced protein ligands. Most notably, the human Vγ9Vδ2 subset reacts to phosphoantigens produced by both microbial pathogens and dysregulated tumor cell metabolism, requiring the presence of accessory proteins butyrophilin 3A1 (BTN3A1) and butyrophilin 2A1 (BTN2A1) for activation. Engagement of phosphoantigens by BTN3A1 (plus BTN2A1) alters their conformation and enables interaction with the γδ TCR, leading to rapid T-cell activation, cytokine release, and direct killing of target cells. This pathway has made γδ TCR an attractive target for cancer and infectious disease immunotherapy, but clinical translation has been limited by imperfect efficacy, complex activation requirements, and immune regulatory effects, including possible self-limiting responses and suppression of natural killer cell function.

Other names

Vγ9Vδ2 T-cell receptorGamma-delta TCRTCRγδGamma-delta T cell antigen receptor

Activation of γδ T cells via recognition of phosphoantigens presented on cell surfaces with involvement of butyrophilin proteins, leading to cytokine release and cytotoxic response